Researchmoz Global Pvt. Ltd.

ResearchMoz : China Heparin Industry Report Trend and Analysis Share 2014-2017

Most up-to-date research on "China Heparin Industry Report, 2014-2017" to its huge collection of research reports.

 

Albany, NY -- (SBWIRE) -- 12/12/2014 -- As the world's major heparin API producer and exporter, China boasts enormous raw materials, which provides a strong support for the production of China's heparin products. In 2013, the live pigs raised in China could manufacture 27.9 trillion units of heparin crude products. And in H1 2014, the live hogs in China may produce 14.09 trillion units of heparin crude products, up 5.6% on a year-on-year basis.

Browse Detail Report With TOC
http://www.researchmoz.us/china-heparin-industry-report-2014-2017-report.html

In 2011-2013, affected by the economic downturn in Europe and America, the global heparin preparations market continued to drop, with the sales volume of main heparin preparations brands virtually presenting decline, thus dragging down the exports of China's heparin products. In 2013, China exported approximately 13.68 trillion units of heparin and its salts, falling 5.9% year on year, and the figure edged down 0.6% from a year earlier to around 9.32 trillion units in Jan.-Aug. 2014.

The major global heparin API suppliers, including Hepalink, Nanjing King-friend, Dongcheng Biochemicals, Qianhong Bio-pharma, and Changshan Biochemical Pharmaceutical, have been among the top 4 heparin exporters in China for many years, together accounting for over 60% of China's total heparin exports. In response to the impact from international markets, enterprises are stepping up efforts to figure out the solutions, with Hepalink expanding its market share of heparin crude products via M&As overseas. By contrast, the enterprises like Qianhong Bio-pharma, Dongcheng Biochemicals, and Changshan Biochemical Pharmaceutical have accelerated the R&D into and production of low molecular weight heparin preparations. And Nanjing King-friend is aggressively seeking to expand capacity through IPO.

For Market Research Latest Reports Visit
http://www.researchmoz.us/latest-report.html

Although the leading heparin enterprises planned to increase capacity and improve the heparin industry chain a few years ago, yet quite a few heparin API projects that had been scheduled to go into operation in 2014 were delayed successively due to depressed market demand or improved technical standards, these projects including Dongcheng Biochemicals' 32t/a Crude Heparin Sodium Project and Qianhong Bio-pharma's Heparin API and Preparations Expansion Project.

In terms of the proposed/ongoing projects, however, it is projected that the heparin API in China will achieve an additional capacity of more than 20 trillion units by 2015, when China's total capacity will exceed 30 trillion units, accounting for roughly 80% of the global demand.

Given that America's economy showed signs of recovery and the European economy did not continue to deteriorate, we foresee that the market size of the global heparin API and preparation market will bounce back in 2014-2017, when China's heparin industry, heparin API in particular, will see an improved degree of prosperity, thus further releasing new capacity.

Browse All Reports in Biotechnology Category
http://www.researchmoz.us/biotechnology-market-reports-30.html

Related Reports

Genomics Deals and Alliances of 2013

(http://www.researchmoz.us/genomics-deals-and-alliances-of-2013-report.html)

The Genomics Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view...

Antibody Deals and Alliances of 2013

(http://www.researchmoz.us/antibody-deals-and-alliances-of-2013-report.html)

The Antibody Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to...

For More Reports Browse
https://www.linkedin.com/today/author/68229468

About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:
Email: sales@researchmoz.us